Medtronic Chief Medical Officer for Acute Care & Monitoring (ACM) Dr. Sam Ajizian announced on LinkedIn that he is leaving the company. “Today is my last day with Medtronic,” Ajizian wrote today. “After almost 10 years serving millions of patients and caregivers globally, I am excited about my next chapter. You’ll hear more about that […]
Medtronic
PaceMate acquires Medtronic cardiac workflow platform
PaceMate announced today that it acquired the Paceart Optima on-premises cardiac workflow solution from Medtronic . The acquisition expands PaceMate’s global reach by adding nearly 1,000 clinic locations worldwide. Sarasota, Florida-based PaceMate said it enhances its ability to provide its comprehensive cardiac remote monitoring solution and cardiac data management. Medtronic’s Cardiac Rhythm Management (CRM) business […]
Medtronic earns expanded MRI labeling for DBS systems
Medtronic announced today that the FDA approved expanded MRI labeling for its deep brain stimulation (DBS) systems. The FDA approved expanded labeling for the Medtronic Percept PC and RC, as well as the Activa PC, RC and SC systems. This labeling approval, exclusive to Medtronic DBS systems, allows for additional active scan time for scans […]
The 9 largest diabetes tech companies in the world
Diabetes technology comes in all shapes and sizes: insulin delivery systems, continuous glucose monitors and more. The companies that develop these technologies come in all shapes and sizes, too. Some focus entirely (or almost entirely) on solutions for people with diabetes. Others are much larger medtech firms that still have sizable business units that focus […]
Medtronic beats The Street in Q1 as it ups lower end of guidance
Medtronic today reported first-quarter results that beat the Wall Street analyst consensus, with automated insulin pumps, PFA and neuromodulation among the medtech fueling the beat. The world’s largest medical device company also nudged up the lower end of its full-year guidance. Truist analysts described the Q1 beat as modest. MDT shares were up more than […]
Medtronic discloses $3M severance payout for EVP’s layoff
Medtronic‘s layoff of a top executive cost more than $3 million in severance, the company said in a new filing with the U.S. Securities and Exchange Commission. Medtronic eliminated former EVP and Medical Surgical President Bob White’s position this year when it pulled out of the ventilator market. Because it terminated White’s employment without cause, […]
Medtronic, Recor Medical earn CMS NTAP wins for renal denervation tech
Medtronic and Recor Medical earned a reimbursement win for their renal denervation (RDN) platforms with a new Final Rule from CMS. CMS posted its FY25 Inpatient Prospective Payment System (IPPS) Final Rule, which includes the New Technology Add-on Payment (NTAP) program. NTAP supports access for newly approved, innovative technologies where the cost to adopt may […]
Medtronic wins FDA nod for asleep deep brain stimulation surgery
Medtronic announced today that it received FDA approval for asleep deep brain stimulation (DBS) surgery for people with Parkinson’s and essential tremor (ET). The medtech giant says it’s the first and only company to win FDA approval to offer DBS surgery while a patient is asleep (under general anesthesia) or awake. “Asleep DBS offers a […]
Recall of Medtronic nerve monitoring tech is Class I
The FDA identified a recall of Medtronic nerve monitoring systems as Class I, the most serious kind of recall. This recall involves correcting devices, not removing them from the market. The device may cause serious injury or death if people continue using it without correction, the FDA says. Medtronic’s correction involves its NIM vital nerve […]
Medtronic wins FDA nod for next-gen Simplera CGM
Medtronic got another boost for its CGM portfolio, adding to the collaboration with Abbott announced today. Our sibling site, Drug Delivery Business News, reported today that the medtech giant received FDA approval for its Simplera continuous glucose monitor (CGM). Simplera, the company’s first disposable, all-in-one CGM, comes in at half the size of previous Medtronic CGMs. Its […]
Abbott, Medtronic partner to connect CGM, insulin delivery systems
Abbott and Medtronic today announced a major partnership in the diabetes technology space. Our sibling site, Drug Delivery Business News, reported today that the companies agreed to a global partnership pairing Abbott CGMs with Medtronic insulin delivery systems. Abbott and Medtronic want to collaborate on a system based on Abbott’s FreeStyle Libre continuous glucose monitors (CGMs) with […]
